This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Default Category
-
What Went Wrong with Boeing's 737 Max
George, William W.; Migdal, AmramCase HBS-320104-EBusiness Ethics and Corporate Social Responsibilitythe crash of Lion Air flight 610 on October 29, 2018, in Indonesia, and the crash of Ethiopian Airlines flight 302 on March 9, 2019, in Ethiopia. The evolution of Boeing's organization and management is described, focusing on the span from Boeing's 1997 merger with rival McDonnell Douglas through the development of the 737 Max and the crashes. The case examines the antecedents and possible causes of the crashes, both through the lens of industry...Starting at €8.20
-
Novartis: Leading a Global Enterprise
George, William W.; Palepu, Krishna G.; Knoop, Carin-IsabelCase HBS-413096-ENovartis, the world's leading healthcare company, was formed in 1996 out of a merger of two very different, mid-tier Switzerland-based pharma companies. The case traces the company's evolution over the past 17 years, as it transformed into a truly global enterprise with 127,000 employees of 153 nationalities in 140 countries generating $56.7 billion in 2012 revenues and $9.6 billion in net income, making the firm one of the world's largest and mo...Starting at €8.20
-
Oprah!, Teaching Note
George, William W.Teaching Note HBS-408117-ELeadership and People ManagementTeaching Note for [405087].Starting at €0.00
-
Martin Luther King, Jr.: A Young Minister Confronts the Challenges of Montgomery, Teaching Note
George, William W.Teaching Note HBS-408102-ELeadership and People ManagementTeaching Note for [406016].Starting at €0.00
-
Facebook Confronts a Crisis of Trust
George, William W.; Migdal, AmramCase HBS-318145-EKnowledge and CommunicationStarting at €8.20
-
Novartis: el liderazgo de una empresa global
George, William W.; Palepu, Krishna G.; Knoop, Carin-IsabelCase HBS-418S09StrategyNovartis, empresa de salud más importantes del mundo, se formó en 1996 de la fusión de dos compañías farmacéuticas muy diferente, de nivel medio con sede en Suiza. El caso describe la evolución de la compañía durante los últimos 17 años, ya que se transformó en una empresa verdaderamente global, con 127.000 empleados de 153 nacionalidades en 140 países y generando $ 56,7 mil millones en 2012 ingresos y $ 9.6 mil millones en ingresos netos, por lo...Starting at €8.20
-
Andrea Jung: Empowering Avon Women (A)
George, William W.Case HBS-408035-ELeadership and People ManagementIn October 2005 Andrea Jung is coping with a 30% decline in Avon's stock price--the biggest test of her leadership since she became CEO in 2000.Starting at €8.20